Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – Giving high-flow oxygen therapy for 15 minutes to emergency department patients with headaches provides rapid relief and reduces hospital stays, use of CT…
NEW YORK (Reuters Health) – In utero exposure to selective serotonin reuptake inhibitors (SSRIs) may increase the risk of early delivery, low Apgar score at 5 minutes, and…
NEW YORK (Reuters Health) – Sildenafil (Viagra) is associated with a number of side effects, but data on long-term harms are still lacking, a systematic review and meta-analysis…
NEW YORK (Reuters Health) – Implantation of a cardioverter-defibrillator (ICD) early after acute myocardial infarction does not decrease overall mortality, investigators report October 8 in The New England…
NEW YORK (Reuters Health) – In non-diabetic patients with hypertensive kidney disease, the risk of hyperkalemia with angiotensin converting enzyme (ACE) inhibitors is “small,” according to research reported…
NEW YORK (Reuters Health) – People over 75 years who undergo colonoscopy or flexible sigmoidoscopy are six times more likely to experience a colon perforation than younger individuals,…
NEW YORK (Reuters Health) – Upper gastrointestinal tract pathology appears to be the norm, not the exception, in patients with obstructive sleep apnea (OSA) and in people who…
Alan Greene, MD, FAAP, Clinical Professor of Pediatrics at Stanford University School of Medicine, talks about his book “Feeding Baby Green”, and his “tomato theory”, describing first how…
NEW YORK (Reuters Health) – Radiofrequency tissue volume reduction (RFTVR) of the soft palate combined with partial uvulectomy is a relatively safe and effective treatment for primary snoring,…
NEW YORK (Reuters Health) – For now at least, the U.S. Preventive Services Task Force (USPSTF) does not recommend that nontraditional risk factors for coronary heart disease be…
